Cargando…
Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1
BACKGROUND: Prognostic classification of metastatic melanoma patients treated with anti-PD-1 is of great interest to clinicians. OBJECTIVE: We aimed to determine the anti-PD-1 treatment related prognostic performance of demographics, clinical and histological prognostic markers and baseline serum S1...
Autores principales: | Janka, Eszter Anna, Ványai, Beatrix, Szabó, Imre Lőrinc, Toka-Farkas, Tünde, Várvölgyi, Tünde, Kapitány, Anikó, Szegedi, Andrea, Emri, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472446/ https://www.ncbi.nlm.nih.gov/pubmed/37664072 http://dx.doi.org/10.3389/fonc.2023.1237643 |
Ejemplares similares
-
Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis
por: Janka, Eszter Anna, et al.
Publicado: (2021) -
Comparison of Immune and Barrier Characteristics in Scalp and Skin Psoriasis
por: GÁSPÁR, Krisztián, et al.
Publicado: (2020) -
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
por: Gassenmaier, Maximilian, et al.
Publicado: (2021) -
Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis—An In Vitro Study
por: Fidrus, Eszter, et al.
Publicado: (2021) -
Detection of Antimicrobial Peptides in Stratum Corneum by Mass Spectrometry
por: Jenei, Adrienn, et al.
Publicado: (2021)